Stock Details
FMS is Fresenius Medical Care AG & Co. KGaA's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 32.16$. Average daily volumn in 3 months 532.53k. Market cap 17.70B



Stock symbol : FMS. Exchange : NYSE. Currency : USD
Lastest price : 30.20$. Total volume : 689.67k. Market state POST
Click reload if you want to check the lastest price on market!!!

Fresenius Medical Care AG & Co. KGaA (FMS)
Last Price
30.20$
Change
0.09
Volume
689.67k

Previous Close30.11
Open29.89
Day Range29.87-30.37
Bid29.00 x 800
Ask30.27 x 1.2k
Volume689.67k
Average Volume532.53k
Market Cap17.7B
Beta0.94
52 Week Range28.75-42.45
Trailing P/E18.88
Foward P/E9.87
Dividend (Yield %)2.36%
Ex-Dividend Date2022-05-13



Financial Details


According to Fresenius Medical Care AG & Co. KGaA's financial reports the company's revenue in 2021 were 17.62B an decrease(0%) over the years 2020 revenue that were of 17.86B. In 2021 the company's total earnings were 969.31M while total earnings in 2020 were 1.16B(-3.1%).


Loading ...



Organization

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the... United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Market Cap:
17.70B
Revenue:
17.62B
Total Assets:
34.37B
Total Cash:
1.48B


News about "Fresenius Medical Care AG & Co. KGaA"

jpmorgan-chase-co-analysts-give-fresenius-medical-care-ag-co-kgaa-etrfme-a-5100-price-target-image

JPMorgan Chase & Co. Analysts Give Fresenius Medical Care AG & Co. KGaA (ETR:FME) a โ‚ฌ51.00 Price Target

Source from : Defense World - 11 hours ago

Fresenius Medical Care AG & Co. KGaA (ETR:FME โ€“ Get Rating) has been assigned a โ‚ฌ51.00 ($54.26) price target by investment analysts at JPMorgan Chase & Co. in a research report issued on Wednesday, ...See details»


berenberg-bank-reiterates-8220-price-target-for-fresenius-medical-care-ag-co-kgaa-etrfme-image

Berenberg Bank Reiterates โ‚ฌ82.20 Price Target for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Source from : Defense World - 1 days ago

Fresenius Medical Care AG & Co. KGaA (ETR:FME โ€“ Get Rating) has been assigned a โ‚ฌ82.20 ($87.45) price objective by stock analysts at Berenberg Bank in a research report issued to clients and investors ...See details»


Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Significant Decline in Short Interest

Source from : ETF Daily News - 10 days ago

JPMorgan Chase & Co. boosted their target price on Fresenius Medical Care AG & Co. KGaA from โ‚ฌ48.70 ($51.26) to โ‚ฌ51.00 ($53.68) and gave the stock an โ€œunderweightโ€ rating in a research ...See details»


Fresenius Medical Care AG & Co. KGaA

Source from : dgap - 21 days ago

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care reports first quarter results in line with its expectations despite significant headwinds DGAP-News: Fresenius Medical Care AG & Co. KGaA / ...See details»


research-analysts-weekly-ratings-updates-for-fresenius-medical-care-ag-co-kgaa-fme-image

Research Analystsโ€™ Weekly Ratings Updates for Fresenius Medical Care AG & Co. KGaA (FME)

Source from : ETF Daily News - 13 days ago

Fresenius Medical Care AG & Co. KGaA (ETR: FME) has recently received a number of price target changes and ratings updates: Shares of ETR:FME opened at โ‚ฌ58.60 ($61.68) on Thursday. The company has a ...See details»


Fresenius Medical Care AG & Co. Kgaa: Dr. Carla Kriwet To Succeed Rice Powell As Chief Executive Officer Of Fresenius Medical Care

Source from : Middle East North Africa Financial Network - 22 days ago

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Personnel Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius ...See details»


DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet succeeds Rice Powell as CEO of the Management Board of Fresenius Medical Care

Source from : Business Insider - 21 days ago

A magnifying glass. It indicates, "Click to perform a search". DGAP-Ad-hoc: Fresenius Medical Care AG & Co. KGaA / Key word(s): Personnel Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet ...See details»


Fresenius Medical Care goes ex-dividend tomorrow

Source from : Seeking Alpha - 13 days ago

Fresenius Medical Care (NYSE:FMS) had declared EUR 1.35/share quarterly dividend, 0.7% increase from prior dividend of EUR 1.34. Payable May 27; for shareholders of record May 16; ex-div May 13.See details»


Fresenius Medical Care AG & Co. KGaA: Despite Challenges, Fresenius Looking to Grow Profits After a Weak 2021

Source from : Yahoo Finance - 20 days ago

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of September 2021. In addition to providing ...See details»


Fresenius Medical Care AG & Co. KGaA: After Tough Q1, Fresenius Medical Care Maintains Outlook for 2022; Shares Undervalued

Source from : Yahoo Finance - 21 days ago

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of September 2021. In addition to providing ...See details»


Fresenius Medical Care(FMS)

Source from : The Motley Fool - 12 days ago

The company makes and sells products for all forms of kidney dialysis to health-care providers throughout the world, along with providing kidney dialysis treatment and other medical ancillary ...See details»


Fresenius Medical (FMS) Q1 Earnings & Revenues Top Estimates

Source from : Nasdaq - 15 days ago

Fresenius Medical Care AG & Co. KGaA FMS reported first-quarter 2022 adjusted earnings per share (EPS) of 38 cents, which beat the Zacks Consensus Estimate of 30 cents by 26.7%. The bottom line ...See details»


Fresenius Medical Care AG & Co. KGaA

Source from : Wall Street Journal - 10 days ago

Lundbeck A/S, Dentsply Sirona, Inc. A. Gregory Sorensen Member-Supervisory Board Fresenius Medical Care AG & Co. KGaA, Empresa de Servicios Sanitarios de Los Lagos SA, IMRIS, Inc., Fusion ...See details»


Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care

Source from : dgap - 2 month ago

Personnel Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care 03.05.2022 / 22:21 The issuer is solely responsible for the ...See details»